Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer

Breast Cancer Research and Treatment

Volumn 128, Issue 3, 2011, Pages 863-871

  Reeder Hayes, Katherine E ^b,d,e   Bainbridge, John ^b   Meyer, Anne Marie ^b   Amos, Keith D ^b,c,d   Weiner, Bryan J ^a,b   Godley, Paul A ^b,c,d   Carpenter, William R ^a,b,c  

^a The University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c North Carolina Comprehensive Cancer Program   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

Breast cancer; Disparities; Sentinel lymph node biopsy; Surgery; Treatment

Indexed keywords

ESTROGEN RECEPTOR;

AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER REGISTRY; CANCER STAGING; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAID; MEDICALLY UNDERSERVED; MEDICARE; MORBIDITY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RACE DIFFERENCE; SENTINEL LYMPH NODE BIOPSY; SOCIAL STATUS; TUMOR DIFFERENTIATION;

EID: 79960839885     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1398-1     Document Type: Article

References (40)

1. PA Cabanes RJ Salmon JR Vilcoq JC Durand A Fourquet C Gautier B Asselain 1992 Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The breast carcinoma collaborative group of the institut curie Lancet 339 8804 1245 1248 1349666 10.1016/0140-6736(92)91591-U 1:STN:280:DyaK383lt1GgsA%3D%3D
2. RK Orr 1999 The impact of prophylactic axillary node dissection on breast cancer survival-a Bayesian meta-analysis Ann Surg Oncol 6 1 109 116 10030423 10.1007/s10434-999-0109-1 1:STN:280:DyaK1M7ltlCqtg%3D%3D (Pubitemid 29077496)
3. GH Lyman AE Giuliano MR Somerfield AB Benson 3rd DC Bodurka HJ Burstein AJ Cochran HS Cody 3rd SB Edge S Galper JA Hayman TY Kim CL Perkins DA Podoloff VH Sivasubramaniam RR Turner R Wahl DL Weaver AC Wolff EP Winer 2005 American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 30 7703 7720 10.1200/JCO.2005.08.001 16157938 10.1200/JCO.2005.08.001 (Pubitemid 46291835)
4. A Lucci LM McCall PD Beitsch PW Whitworth DS Reintgen PW Blumencranz AM Leitch S Saha KK Hunt AE Giuliano 2007 Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011 J Clin Oncol 25 24 3657 3663 10.1200/JCO.2006.07.4062 17485711 10.1200/JCO.2006.07.4062 (Pubitemid 47372604)
5. DN Krag TB Julian SP Harlow DL Weaver T Ashikaga J Bryant RM Single N Wolmark 2004 NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial Ann Surg Oncol 11 3 Suppl 208S 210S 15023753
6. Krag DN, Anderson SJ, Julian TB, Brown A, Harlow SP, Costantino JP, Ashikaga T, Weaver D, Mamounas EP, Wolmark N (2010) Primary outcome results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients. J Clin Oncol (Meeting Abstracts) 28 (18-suppl):LBA505
7. MA Maggard KE Lane JB O'Connell DD Nanyakkara CY Ko 2005 Beyond the clinical trials: how often is sentinel lymph node dissection performed for breast cancer? Ann Surg Oncol 12 1 41 47 10.1007/s10434-004-1168-y 15827777 10.1007/s10434-004-1168-y (Pubitemid 40486640)
8. AY Chen MT Halpern NM Schrag A Stewart M Leitch E Ward 2008 Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005) J Natl Cancer Inst 100 7 462 474 10.1093/jnci/djn057 18364506 10.1093/jnci/djn057
9. MT Halpern AY Chen NS Marlow E Ward 2009 Disparities in receipt of lymph node biopsy among early-stage female breast cancer patients Ann Surg Oncol 16 3 562 570 10.1245/s10434-008-0205-7 18998064 10.1245/s10434-008-0205-7
10. MJ Lund OP Brawley KC Ward JL Young SS Gabram JW Eley 2008 Parity and disparity in first course treatment of invasive breast cancer Breast Cancer Res Treat 109 3 545 557 10.1007/s10549-007-9675-8 17659438 10.1007/s10549-007-9675-8 (Pubitemid 351692062)
11. RA Freedman Y He EP Winer NL Keating 2009 Trends in racial and age disparities in definitive local therapy of early-stage breast cancer J Clin Oncol 27 5 713 719 10.1200/JCO.2008.17.9234 19103731 10.1200/JCO.2008.17.9234
12. NA Bickell JJ Wang S Oluwole D Schrag H Godfrey K Hiotis J Mendez AA Guth 2006 Missed opportunities: racial disparities in adjuvant breast cancer treatment J Clin Oncol 24 9 1357 1362 10.1200/JCO.2005.04.5799 16549830 10.1200/JCO.2005.04.5799 (Pubitemid 46621998)
13. DA Haggstrom C Quale R Smith-Bindman 2005 Differences in the quality of breast cancer care among vulnerable populations Cancer 104 11 2347 2358 10.1002/cncr.21443 16211547 10.1002/cncr.21443 (Pubitemid 41691555)
14. Smith GL, Shih YC, Xu Y, Giordano SH, Smith BD, Perkins GH, Tereffe W, Woodward WA, Buchholz TA (2010) Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study. Cancer 116 (3):734-741. doi: 10.1002/cncr.24741
15. NL Keating E Kouri Y He JC Weeks EP Winer 2009 Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care 47 7 765 773 10.1097/MLR.0b013e31819e1fe7 19536008 10.1097/MLR.0b013e31819e1fe7
16. KC Chu CA Lamar HP Freeman 2003 Racial disparities in breast carcinoma survival rates: seperating factors that affect diagnosis from factors that affect treatment Cancer 97 11 2853 2860 10.1002/cncr.11411 12767100 10.1002/cncr.11411 (Pubitemid 36605155)
17. E Curtis C Quale D Haggstrom R Smith-Bindman 2008 Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 112 1 171 180 10.1002/cncr.23131 18040998 10.1002/cncr.23131
18. KI Bland CE Scott-Conner H Menck DP Winchester 1999 Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival J Am Coll Surg 188 6 586 595 10359351 10.1016/S1072-7515(99)00056-3 1:STN:280: DyaK1M3osFyrtg%3D%3D discussion 595-586 (Pubitemid 29247073)
19. JS Mandelblatt JF Kerner J Hadley YT Hwang L Eggert LE Johnson K Gold 2002 Variations in breast carcinoma treatment in older medicare beneficiaries: is it black or white Cancer 95 7 1401 1414 10.1002/cncr.10825 12237908 10.1002/cncr.10825
20. A Hurria FL Wong D Villaluna S Bhatia CT Chung J Mortimer S Hurvitz A Naeim 2008 Role of age and health in treatment recommendations for older adults with breast cancer: the perspective of oncologists and primary care providers J Clin Oncol 26 33 5386 5392 10.1200/JCO.2008.17.6891 18955446 10.1200/JCO.2008.17.6891
21. C Owusu TL Lash RA Silliman 2007 Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women Breast Cancer Res Treat 102 2 227 236 10.1007/s10549-006-9321-x 17004115 10.1007/s10549-006-9321-x (Pubitemid 46452169)
22. HB Muss S Woolf D Berry C Cirrincione RB Weiss D Budman WC Wood IC Henderson C Hudis E Winer H Cohen J Wheeler L Norton 2005 Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer JAMA 293 9 1073 1081 10.1001/jama.293.9.1073 15741529 10.1001/jama.293.9.1073 1:CAS:528:DC%2BD2MXitVSnsLY%3D (Pubitemid 40300281)
23. HB Muss DA Berry C Cirrincione DR Budman IC Henderson ML Citron L Norton EP Winer CA Hudis 2007 Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience J Clin Oncol 25 24 3699 3704 10.1200/JCO.2007.10.9710 17704418 10.1200/JCO.2007.10.9710 1:CAS:528:DC%2BD2sXhtVeqt7fP (Pubitemid 47372610)
24. Early Breast Cancer Trialists' Collaborative Group (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352 (9132):930-942
25. Altekruse S, Kosary C, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner M, Lewis D, Cronin K, Chen H, Feuer E, Stinchcomb D, Edwards BK (eds) (2010) SEER Cancer Statistics Review, 1975-2007. National Cancer Institute, Bethesda, MD
26. L Laliberte ML Fennell G Papandonatos 2005 The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer Med Care 43 5 471 479 15838412 10.1097/01.mlr.0000160416.66188.f5 (Pubitemid 40694608)
27. KY Bilimoria CM Balch JD Wayne DC Chang BE Palis SM Dy JR Lange 2009 Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States J Clin Oncol 27 11 1857 1863 10.1200/JCO.2008.18.7567 19273706 10.1200/JCO.2008.18.7567
28. T Onega EJ Duell X Shi E Demidenko D Gottlieb DC Goodman 2009 Influence of NCI cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients Med Care Res Rev 66 5 542 560 10.1177/1077558709335536 19454624 10.1177/1077558709335536
29. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40 (8 Suppl):IV-3-18. doi: 10.1097/01.MLR.0000020942.47004.03
30. Carpenter WR, Reeder-Hayes K, Bainbridge J, Meyer AM, Amos KD, Weiner BJ, Godley PA (2011) The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation. Med Care 49 (2):172-179. doi: 10.1097/MLR.0b013e3182028ff2
31. A Ghafoor A Jemal E Ward V Cokkinides R Smith M Thun 2003 Trends in breast cancer by race and ethnicity CA Cancer J Clin 53 6 342 355 15224974 10.3322/canjclin.53.6.342 (Pubitemid 38081592)
32. TA Michalski AB Nattinger 1997 The influence of black race and socioeconomic status on the use of breast-conserving surgery for Medicare beneficiaries Cancer 79 2 314 319 10.1002/(SICI)1097-0142(19970115)79:2<314:: AID-CNCR14>3.0.CO;2-3[pii] 9010104 10.1002/(SICI)1097-0142(19970115)79: 2<314::AID-CNCR14>3.0.CO;2-3 1:STN:280:DyaK2s7mtlaluw%3D%3D (Pubitemid 27029895)
33. Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA (2009) Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg 209 (4):425-433 e422. doi: 10.1016/j.jamcollsurg. 2009.06.363
34. SB Edge K Gold CD Berg NJ Meropol TN Tsangaris L Gray BM Petersen Jr YT Hwang JS Mandelblatt 2002 Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma Cancer 94 10 2534 2541 12173318 10.1002/cncr.10540 (Pubitemid 34478065)
35. SM Koroukian F Xu A Dor GS Cooper 2006 Colorectal cancer screening in the elderly population: disparities by dual Medicare-Medicaid enrollment status Health Serv Res 41 6 2136 2154 10.1111/j.1475-6773.2006.00585.x 17116113 10.1111/j.1475-6773.2006.00585.x (Pubitemid 44760147)
36. SP Harlow DN Krag 2001 Sentinel lymph node biopsy in breast cancer Breast Dis 12 43 55 15687606 1:STN:280:DC%2BD2M%2FlvVWmtg%3D%3D (Pubitemid 32834268)
37. CE Cox S Pendas JM Cox E Joseph AR Shons T Yeatman NN Ku GH Lyman C Berman F Haddad DS Reintgen 1998 Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer Ann Surg 227 5 645 651 9605656 10.1097/00000658-199805000-00005 1:STN:280:DyaK1c3ms1KqsQ%3D%3D discussion 651-643 (Pubitemid 28530914)
38. RK Orr JL Hoehn NF Col 1999 The learning curve for sentinel node biopsy in breast cancer: practical considerations Arch Surg 134 7 764 767 10401830 10.1001/archsurg.134.7.764 1:STN:280:DyaK1MzivVamtQ%3D%3D (Pubitemid 29316117)
39. JA Olson Jr LM McCall P Beitsch PW Whitworth DS Reintgen PW Blumencranz AM Leitch S Saha KK Hunt AE Giuliano 2008 Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011 J Clin Oncol 26 21 3530 3535 10.1200/JCO.2007.15. 5630 18640934 10.1200/JCO.2007.15.5630
40. DN Krag SJ Anderson TB Julian AM Brown SP Harlow T Ashikaga DL Weaver BJ Miller LM Jalovec TG Frazier RD Noyes A Robidoux HM Scarth DM Mammolito DR McCready EP Mamounas JP Costantino N Wolmark 2007 Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 10 881 888 10.1016/S1470-2045(07) 70278-4 17851130 10.1016/S1470-2045(07)70278-4 1:CAS:528:DC%2BD2sXhtFektbzM (Pubitemid 47488052)